Back to Search
Start Over
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
- Source :
- The Lancet. 401:843-855
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- General Medicine
Subjects
Details
- ISSN :
- 01406736
- Volume :
- 401
- Database :
- OpenAIRE
- Journal :
- The Lancet
- Accession number :
- edsair.doi...........b5b016c952705e54629bce4582dc07a8
- Full Text :
- https://doi.org/10.1016/s0140-6736(22)02644-7